Patient-controlled Versus Anesthesiologist-controlled Propofol-remifentanil in Awake Craniotomy
|ClinicalTrials.gov Identifier: NCT00992940|
Recruitment Status : Withdrawn (Funds needed to carry on the project were not secured.)
First Posted : October 9, 2009
Last Update Posted : January 9, 2013
|Condition or disease||Intervention/treatment|
|Awake Craniotomy for Brain Tumour Surgery||Procedure: Patient-Controlled Sedation/Analgesia Procedure: Anesthetist-Controlled Sedation/Analgesia|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||0 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||A Comparison of Patient-controlled Versus Anesthesiologist-controlled Propofol-remifentanil in Awake Craniotomy for Tumor Surgery|
Experimental: Patient-Controlled Sedation/Analgesia
Patient controls the amount of sedation and analgesia delivered, according to their own requirements.
Procedure: Patient-Controlled Sedation/Analgesia
Patient controls delivery of sedation and analgesia requirements.
Active Comparator: Anesthetist-Controlled Sedation/Analgesia
Patient sedation and analgesia requirements are delivered by the anesthetist.
Procedure: Anesthetist-Controlled Sedation/Analgesia
All sedation and analgesia requirements are determined and delivered by the attending anesthetist.
- To assess the ability of patient-controlled sedation/analgesia remifentanil-propofol to maintain appropriate levels of sedation and analgesia in commensuration with the needs of the surgery at different stages. [ Time Frame: 2 hours, 24 hours ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00992940
|Toronto Western Hospital, University Health Network|
|Toronto, Ontario, Canada, M5T 2S8|
|Principal Investigator:||Pirjo Manninen, MD||University Health Network, Toronto|